EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Pulsed field ablation technology for pulmonary vein and left atrial posterior wall isolation in patients with persistent atrial fibrillation

Marco Schiavone iD, Francesco Solimene, Massimo Moltrasio, Michela Casella, Stefano Bianchi, Saverio Iacopino iD, Antonio Rossillo iD, Vincenzo Schillaci, Gaetano Fassini, Paolo Compagnucci iD, Armando Salito, Pietro Rossi und 8 weitere

Journal of Cardiovascular Electrophysiology · 2024

DOI: 10.1111/jce.16246 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2024. Verfasst von Marco Schiavone und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Electrophysiology & Cardiac Pacing, Centro Cardiologico Monzino, IRCCS, Milan, Italy. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins, Catheter Ablation, Recurrence. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Limited data exist on pulsed‐field ablation (PFA) in patients with persistent atrial fibrillation (PeAF) undergoing left atrial posterior wall isolation (LAPWI).

Methods

The Advanced TecHnologies For SuccEssful AblatioN of AF in Clinical Practice (ATHENA) prospective registry included consecutive patients referred for PeAF catheter ablation at 9 Italian centers, treated with the FARAPULSE TM ‐PFA system. The primary efficacy and safety study endpoints were the acute LAPWI rate, freedom from arrhythmic recurrences and the incidence of major periprocedural complications. Patients undergoing pulmonary vein isolation (PVI) alone, PWI + LAPWI and redo procedures were compared.

Results

Among 249 patients, 21.7% had long‐standing PeAF, 79.5% were male; mean age was 63 ± 9 years. LAPWI was performed in 57.6% of cases, with 15.3% being redo procedures. Median skin‐to‐skin times (PVI‐only 68 [60−90] vs. PVI + LAPWI 70 [59−88] mins) did not differ between groups. 45.8% LAPWI cases were approached with a 3D‐mapping system, and 37.3% with intracardiac echocardiography. LAPWI was achieved in all patients by means of PFA alone, in 88.8% cases at first pass. LAPWI was validated either by an Ultrahigh‐density mapping system or by recording electrical activity + pacing maneuvers. No major complications occurred, while 2.4% minor complications were detected. During a median follow‐up of 273 [191–379] days, 41 patients (16.5%) experienced an arrhythmic recurrence after the 90‐day blanking period, with a mean time to recurrence of 223 ± 100 days and no differences among ablation strategies.

Conclusion

LAPWI with PFA demonstrates feasibility, rapidity, and safety in real‐world practice, offering a viable alternative for PeAF patients. LAPWI is achievable even with a fluoroscopy‐only method and does not significantly extend overall procedural times.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationPulmonary VeinsCatheter AblationRecurrenceRegistriesAction PotentialsHeart RateHumansMaleFemaleMiddle AgedAgedProspective StudiesTime FactorsItalyRisk FactorsHeart AtriaTreatment OutcomeProgression-Free Survival

Stichwörter der Autor:innen

atrial fibrillationelectroporationleft atrial posterior wall isolationpulsed‐field ablation

Autor:innen und Institutionen

  • Department of Clinical Electrophysiology & Cardiac Pacing, Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Montevergine Clinic, Mercogliano, Avellino, Italy.
  • Department of Biomedical Sciences and Public Health, Marche Polytechnic University, Ancona, Italy.
  • Department of Cardiology and Arrhythmology Clinic, University Hospital Ospedali Riuniti Umberto I-Lancisi-Salesi, Ancona, Italy.
  • Department of Clinical, Special and Dental Sciences, Marche Polytechnic University, Ancona, Italy.

ORCID-Profile: Marco Schiavone, Saverio Iacopino, Antonio Rossillo, Paolo Compagnucci, Claudio Pandozi, Maurizio Malacrida

Zitieren

APA

Schiavone, M., Solimene, F., Moltrasio, M., Casella, M., Bianchi, S., Iacopino, S., Rossillo, A., Schillaci, V., Fassini, G., Compagnucci, P., Salito, A., Rossi, P., Filannino, P., Maggio, R., Themistoklakis, S., Pandozi, C., Caprioglio, F., Malacrida, M., Russo, A. D., & Tondo, C. (2024). Pulsed field ablation technology for pulmonary vein and left atrial posterior wall isolation in patients with persistent atrial fibrillation. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16246

Vancouver

Schiavone M, Solimene F, Moltrasio M, Casella M, Bianchi S, Iacopino S, et al. Pulsed field ablation technology for pulmonary vein and left atrial posterior wall isolation in patients with persistent atrial fibrillation. Journal of Cardiovascular Electrophysiology. 2024. doi:10.1111/jce.16246

BibTeX
@article{Schiavone2024,
  author = {Schiavone, Marco and Solimene, Francesco and Moltrasio, Massimo and Casella, Michela and Bianchi, Stefano and Iacopino, Saverio and Rossillo, Antonio and Schillaci, Vincenzo and Fassini, Gaetano and Compagnucci, Paolo and Salito, Armando and Rossi, Pietro and Filannino, Pasquale and Maggio, Ruggero and Themistoklakis, Sakis and Pandozi, Claudio and Caprioglio, Francesco and Malacrida, Maurizio and Russo, Antonio Dello and Tondo, Claudio},
  title = {Pulsed field ablation technology for pulmonary vein and left atrial posterior wall isolation in patients with persistent atrial fibrillation},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2024},
  doi = {10.1111/jce.16246}
}
Kostenlos starten →